GlassScriptPhysician profile
Stacey C Basquin
NPI 1760549919
$11,237.25
in general payments reported to CMS, 2019-2025
41 companies · $3,316 in 2025
The $3,316 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.00 · 2021: $1,954 · 2022: $1,830 · 2023: $1,574 · 2024: $2,465 · 2025: $3,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,624 · Consulting Fee: $400 · Education: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,624.35 |
| Consulting Fee | $400.00 |
| Education | $329.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,398.03 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,333.47 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $852.59 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Insmed, INC. | $693.60 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $573.53 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.70 | 2021-2025 | Ofev, Stiolto Respimat, Jascayd |
| Bayer Healthcare Pharmaceuticals INC. | $522.92 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $474.58 | 2021-2025 | |
| Mylan Specialty L.P. | $468.10 | 2021-2024 | Yupelri |
| Harmony Biosciences LLC | $456.98 | 2021-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $391.23 | 2021-2025 | Glassia |
| Merck Sharp & Dohme LLC | $378.71 | 2023-2025 | Winrevair, Keytruda, Capvaxive |
| Axsome Therapeutics, INC. | $357.83 | 2022-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $356.29 | 2023-2025 | Lumryz |
| Grifols USA, LLC | $355.96 | 2021-2025 | Prolastin-C Liquid |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $279.78 | 2021-2024 | Orenitram, Remodulin |
| Genzyme Corporation | $207.25 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $178.94 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $172.85 | 2024-2025 | Purified Cortrophin Gel |
| Verona Pharma, INC. | $172.27 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $155.93 | 2021-2023 | Acthar |
| Abbvie INC. | $102.32 | 2022-2024 | |
| Vifor Pharma, INC. | $80.91 | 2021-2025 | Zemaira, Veltassa |
| Amgen INC. | $80.05 | 2022-2025 | Tezspire |
| Electromed, INC. | $75.51 | 2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $72.77 | 2021 | |
| Baxter Healthcare | $64.30 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $53.38 | 2021 | |
| Medtronic, INC. | $53.13 | 2021-2024 | Illumisite |
| Viatris Specialty LLC | $50.92 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $43.97 | 2023 | Quviviq |
| Pfizer INC. | $42.10 | 2021-2025 | |
| Olympus America INC. | $36.40 | 2021-2022 | |
| Johnson & Johnson Health Care Systems INC. | $30.75 | 2023 | Opsumit |
| Stryker Corporation | $27.58 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $21.20 | 2022 | |
| La Jolla Pharmaceutical Company | $20.42 | 2022 | |
| Lilly USA, LLC | $19.00 | 2025 | Zepbound |
| Philips North America LLC | $17.38 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.81 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Basquin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.